{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:50:35Z","timestamp":1768031435116,"version":"3.49.0"},"reference-count":27,"publisher":"Japanese Society of Toxicology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2131\/jts.51.7","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:10:41Z","timestamp":1767651041000},"page":"7-18","source":"Crossref","is-referenced-by-count":0,"title":["A preliminary evaluation of the applicability of the &lt;i&gt;in vitro&lt;\/i&gt; to &lt;i&gt;in vivo&lt;\/i&gt; extrapolation approach to quantitative risk assessment"],"prefix":"10.2131","volume":"51","author":[{"given":"Kikuo","family":"Yoshida","sequence":"first","affiliation":[{"name":"Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Umano","sequence":"additional","affiliation":[{"name":"Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences"},{"name":"Division of Cellular and Molecular Toxicology, Center for Biological Safety Research, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"DeJongh, J., Verhaar, H.J. and Hermens, J.L. (1997): A quantitative property-property relationship (QPPR) approach to estimate <i>in vitro<\/i> tissue-blood partition coefficients of organic chemicals in rats and humans. Arch. Toxicol., <b>72<\/b>, 17-25.","DOI":"10.1007\/s002040050463"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Fabian, E., Gomes, C., Birk, B., Williford, T., Hernandez, T.R., Haase, C., Zbranek, R., van Ravenzwaay, B. and Landsiedel, R. (2019): In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds. Arch. Toxicol., <b>93<\/b>, 401-416.","DOI":"10.1007\/s00204-018-2372-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Fagerholm, U., Johansson, M. and Lennern\u00e4s, H. (1996): Comparison between permeability coefficients in rat and human jejunum. Pharm. Res., <b>13<\/b>, 1336-1342.","DOI":"10.1023\/A:1016065715308"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Hou, T.J., Zhang, W., Xia, K., Qiao, X.B. and Xu, X.J. (2004): ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties. J. Chem. Inf. Comput. Sci., <b>44<\/b>, 1585-1600.","DOI":"10.1021\/ci049884m"},{"key":"5","unstructured":"Jongeneelen, F.J. and ten Berge, W. (2011). IndusChemFate: A multi-chemical PBTK-model in MS-Excel applicable for workers, consumers and experimental animals User manual, version 2.00. IndusTox Consult, Nijmegen, NL."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Judson, R.S., Magpantay, F.M., Chickarmane, V., Haskell, C., Tania, N., Taylor, J., Xia, M., Huang, R., Rotroff, D.M., Filer, D.L., Houck, K.A., Martin, M.T., Sipes, N., Richard, A.M., Mansouri, K., Setzer, R.W., Knudsen, T.B., Crofton, K.M. and Thomas, R.S. (2015): Integrated model of chemical perturbations of a biological pathway using 18 <i>in vitro<\/i> high-throughput screening assays for the estrogen receptor. Toxicol. Sci., <b>148<\/b>, 137-154.","DOI":"10.1093\/toxsci\/kfv168"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kamiya, Y., Handa, K., Miura, T., Ohori, J., Kato, A., Shimizu, M., Kitajima, M. and Yamazaki, H. (2022): Machine learning prediction of the three main input parameters of a simplified physiologically based pharmacokinetic model subsequently used to generate time-dependent plasma concentration data in humans after oral doses of 212 disparate chemicals. Biol. Pharm. Bull., <b>45<\/b>, 124-128.","DOI":"10.1248\/bpb.b21-00769"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kawashima, H., Watanabe, R., Esaki, T., Kuroda, M., Nagao, C., Natsume-Kitatani, Y., Ohashi, R., Komura, H. and Mizuguchi, K. (2023): DruMAP: A novel drug metabolism and pharmacokinetics analysis platform. J. Med. Chem., <b>66<\/b>, 9697-9709.","DOI":"10.1021\/acs.jmedchem.3c00481"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Li, H., Zhang, M., Vervoort, J., Rietjens, I.M., van Ravenzwaay, B. and Louisse, J. (2017): Use of physiologically based kinetic modeling-facilitated reverse dosimetry of <i>in vitro<\/i> toxicity data for prediction of <i>in vivo<\/i> developmental toxicity of tebuconazole in rats. Toxicol. Lett., <b>266<\/b>, 85-93.","DOI":"10.1016\/j.toxlet.2016.11.017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Nagata, M. and Sugimoto, J. (1973): The influences of drugs on the experimental constipation of mice treated with atropine and papaverine. J. Kansai Med. Univ., <b>25<\/b>, 300-321.","DOI":"10.5361\/jkmu1956.25.3_300"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Noorlander, A., Zhang, M., van Ravenzwaay, B. and Rietjens, I.M. (2022): Use of physiologically based kinetic modeling-facilitated reverse dosimetry to predict <i>in vivo<\/i> acute toxicity of tetrodotoxin in rodents. Toxicol. Sci., <b>187<\/b>, 127-138.","DOI":"10.1093\/toxsci\/kfac022"},{"key":"12","unstructured":"OECD. (2007): Test No. 440: Uterotrophic bioassay in rodents: A short-term screening test for oestrogenic properties. In: OECD Guidelines for the Testing of Chemicals, Sect, 4. OECD Publishing, Paris."},{"key":"13","unstructured":"OECD. (2021): Test No. 455: Performance-based test guideline for stably transfected transactivation <i>in vitro<\/i> assays to detect estrogen receptor agonists and antagonists. In: OECD Guidelines for the Testing of Chemicals, Sect, 4. OECD Publishing, Paris."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Pradeep, P., Patlewicz, G., Pearce, R., Wambaugh, J., Wetmore, B. and Judson, R. (2020): Using chemical structure information to develop predictive models for <i>in vitro<\/i> toxicokinetic parameters to inform high-throughput risk-assessment. Comput. Toxicol., <b>16<\/b>, 100136.","DOI":"10.1016\/j.comtox.2020.100136"},{"key":"15","unstructured":"R Core Team. (2023). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available online at https:\/\/www.R-project.org\/."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Soetaert, K., Petzoldt, T. and Setzer, R. (2010): Solving differential equations in R: package deSolve. J. Stat. Softw., <b>33<\/b>, 1-25.","DOI":"10.18637\/jss.v033.i09"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Sohlenius-Sternbeck, A.K. (2006): Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. Toxicol. In Vitro, <b>20<\/b>, 1582-1586.","DOI":"10.1016\/j.tiv.2006.06.003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Strikwold, M., Spenkelink, B., Woutersen, R.A., Rietjens, I.M. and Punt, A. (2013): Combining <i>in vitro<\/i> embryotoxicity data with physiologically based kinetic (PBK) modelling to define <i>in vivo<\/i> dose-response curves for developmental toxicity of phenol in rat and human. Arch. Toxicol., <b>87<\/b>, 1709-1723.","DOI":"10.1007\/s00204-013-1107-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Strikwold, M., Spenkelink, B., de Haan, L.H., Woutersen, R.A., Punt, A. and Rietjens, I.M. (2017): Integrating <i>in vitro<\/i> data and physiologically based kinetic (PBK) modelling to assess the <i>in vivo<\/i> potential developmental toxicity of a series of phenols. Arch. Toxicol., <b>91<\/b>, 2119-2133.","DOI":"10.1007\/s00204-016-1881-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Sun, D., Lennernas, H., Welage, L.S., Barnett, J.L., Landowski, C.P., Foster, D., Fleisher, D., Lee, K.-D. and Amidon, G.L. (2002): Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm. Res., <b>19<\/b>, 1400-1416.","DOI":"10.1023\/A:1020483911355"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Taylor, J.A., Vom Saal, F.S., Welshons, W.V., Drury, B., Rottinghaus, G., Hunt, P.A., Toutain, P.L., Laffont, C.M. and VandeVoort, C.A. (2011): Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect., <b>119<\/b>, 422-430.","DOI":"10.1289\/ehp.1002514"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wegner, S.H., Pinto, C.L., Ring, C.L. and Wambaugh, J.F. (2020): High-throughput screening tools facilitate calculation of a combined exposure-bioactivity index for chemicals with endocrine activity. Environ. Int., <b>137<\/b>, 105470.","DOI":"10.1016\/j.envint.2020.105470"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Wetmore, B.A., Wambaugh, J.F., Ferguson, S.S., Sochaski, M.A., Rotroff, D.M., Freeman, K., Clewell, H.J. 3rd, Dix, D.J., Andersen, M.E., Houck, K.A., Allen, B., Judson, R.S., Singh, R., Kavlock, R.J., Richard, A.M. and Thomas, R.S. (2012): Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol. Sci., <b>125<\/b>, 157-174.","DOI":"10.1093\/toxsci\/kfr254"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Ye, X., Bishop, A.M., Reidy, J.A., Needham, L.L. and Calafat, A.M. (2006): Parabens as urinary biomarkers of exposure in humans. Environ. Health Perspect., <b>114<\/b>, 1843-1846.","DOI":"10.1289\/ehp.9413"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Yu, L.X. and Amidon, G.L. (1999): A compartmental absorption and transit model for estimating oral drug absorption. Int. J. Pharm., <b>186<\/b>, 119-125.","DOI":"10.1016\/S0378-5173(99)00147-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Zhang, M., van Ravenzwaay, B., Fabian, E., Rietjens, I.M. and Louisse, J. (2018): Towards a generic physiologically based kinetic model to predict <i>in vivo<\/i> uterotrophic responses in rats by reverse dosimetry of <i>in vitro<\/i> estrogenicity data. Arch. Toxicol., <b>92<\/b>, 1075-1088.","DOI":"10.1007\/s00204-017-2140-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Zhang, M., van Ravenzwaay, B. and Rietjens, I.M. (2020): Development of a generic physiologically based kinetic model to predict <i>in vivo<\/i> uterotrophic responses induced by estrogenic chemicals in rats based on <i>in vitro<\/i> bioassays. Toxicol. Sci., <b>173<\/b>, 19-31.","DOI":"10.1093\/toxsci\/kfz216"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/1\/51_7\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:12:02Z","timestamp":1768018322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/1\/51_7\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.51.7","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}